A major discovery in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This vital malignant suppressor protein is frequently inactivated in several kinds of malignancies, https://thebookmarknight.com/story21918893/vhh-fragments-reactivate-tumor-suppressor-p53-the-new-pathway-for-cancer-management